4-aminobenzamidine has been researched along with Antiphospholipid Syndrome in 1 studies
4-aminobenzamidine: a urokinase inhibitor; inhibits acrosin; structure given in first source
Antiphospholipid Syndrome: The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pozzi, N | 1 |
Acquasaliente, L | 1 |
Frasson, R | 1 |
Cristiani, A | 1 |
Moro, S | 1 |
Banzato, A | 1 |
Pengo, V | 1 |
Scaglione, GL | 1 |
Arcovito, A | 1 |
De Cristofaro, R | 1 |
De Filippis, V | 1 |
1 other study available for 4-aminobenzamidine and Antiphospholipid Syndrome
Article | Year |
---|---|
β2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions.
Topics: Anticoagulants; Antiphospholipid Syndrome; Benzamidines; beta 2-Glycoprotein I; Blood Coagulation; C | 2013 |